Study Title
A Tissue and Longitudinal Circulating Tumor DNA (ctDNA) Biomarker Profiling Study of Patients with Small Cell Lung Cancer (SCLC) Using Comprehensive Next-Generation Sequencing (NGS) Assays (TEMPUS)
Study Number
TP-CA-003
Enrollment status
Open
Categories
Extensive Stage SCLC, Lung Cancer, Small Cell Lung Cancer
Study Summary
The study is a non-interventional evaluation of participants with SCLC who will receive diagnostic and (where possible) post-progression tumor tissue profiling, alongside plasma ctDNA biomarker profiling in addition to their standard of care therapy and disease surveillance.
Study Teaser
Tempus Sculptor Study: Small Cell Lung Cancer (SCLC) Observational Study
Study Coordinator
- Trupti, 309-243-3662, thattiangadi@illinoiscancercare.com
Study Link
View Study DetailsComments
Bloomington, Canton, Galesburg, Ottawa, Pekin, Peoria, Peru, Washington clinics